Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases

<p>Supplementary Table S1</p>

保存先:

書誌詳細
第一著者:	Noor Jailkhani (16015810) (author)
その他の著者:	Karl R. Clauser (16015813) (author), Howard H. Mak (14958336) (author), Steffen Rickelt (14942629) (author), Chenxi Tian (16015816) (author), Charles A. Whittaker (15038249) (author), Kenneth K. Tanabe (16015819) (author), Stephen R. Purdy (16015822) (author), Steven A. Carr (14942649) (author), Richard O. Hynes (14942641) (author)
出版事項:	2025
主題:	Cancer Tumor Biology Molecular and Cellular Biology Immuno-oncology Methods and Technology Breast Cancer Imaging Positron emission tomography (PET) Small animal imaging Immunology Antibodies/immunoconjugates Proteomics Tumor Microenvironment
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
著者:: Noor Jailkhani (16015810)
出版事項: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
著者:: Noor Jailkhani (16015810)
出版事項: (2025)

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
著者:: Xiaojiang Duan (15439264)
出版事項: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
著者:: Xiaojiang Duan (15439264)
出版事項: (2025)

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
著者:: Xiaojiang Duan (15439264)
出版事項: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
著者:: Xiaojiang Duan (15439264)
出版事項: (2025)

FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS4 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS5 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS6 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS7 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS8 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

FigureS9 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS 1a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS1b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS1c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS1d from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS2a from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS2b from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary MovieS2c from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
著者:: Jonathan Chou (14957015)
出版事項: (2025)

Supplementary Data S1 from Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
著者:: Steven B. Maron (15044607)
出版事項: (2025)

Alternative Ion-Pairing Modifiers Should Be Investigated in Low-Input and Single-Cell Proteomics
著者:: Colten D. Eberhard (17729446)
出版事項: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
著者:: Abhrajit Ganguly (21540245)
出版事項: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
著者:: Marwa Zafarullah (12527002)
出版事項: (2025)

Figure 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 2 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 4 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 5 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 6 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 7 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Table 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
著者:: Friederike Hesse (14958870)
出版事項: (2025)

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
著者:: Vinton W.T. Cheng (15020397)
出版事項: (2025)

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
著者:: Vinton W.T. Cheng (15020397)
出版事項: (2025)

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
著者:: Vinton W.T. Cheng (15020397)
出版事項: (2025)

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
著者:: Vinton W.T. Cheng (15020397)
出版事項: (2025)

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
著者:: Vinton W.T. Cheng (15020397)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ram4terb1tmjmb91c6q1ed2sp8